Predicting Intention to Receive COVID-19 Vaccination in People Living with HIV using an Integrated Behavior Model
Bramantya Wicaksana,
Evy Yunihastuti,
Hamzah Shatri,
Dicky C. Pelupessy,
Sukamto Koesnoe,
Samsuridjal Djauzi,
Haridana Indah Setiawati Mahdi,
Dyah Agustina Waluyo,
Zubairi Djoerban,
Tommy Hariman Siddiq
Affiliations
Bramantya Wicaksana
Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia—Cipto Mangunkusumo Hospital, Jakarta 10430, Indonesia
Evy Yunihastuti
Allergy and Clinical Immunology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo Hospital, Jakarta 10430, Indonesia
Hamzah Shatri
Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia—Cipto Mangunkusumo Hospital, Jakarta 10430, Indonesia
Dicky C. Pelupessy
Faculty of Psychology, Universitas Indonesia, Depok 16424, Indonesia
Sukamto Koesnoe
Allergy and Clinical Immunology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo Hospital, Jakarta 10430, Indonesia
Samsuridjal Djauzi
Department of Non-Oncology Internal Medicine, Dharmais National Cancer Hospital, Jakarta 11420, Indonesia
Haridana Indah Setiawati Mahdi
Department of Non-Oncology Internal Medicine, Dharmais National Cancer Hospital, Jakarta 11420, Indonesia
Dyah Agustina Waluyo
Kramat 128 Hospital, Jakarta 10430, Indonesia
Zubairi Djoerban
Kramat 128 Hospital, Jakarta 10430, Indonesia
Tommy Hariman Siddiq
Faculty of Psychology and Education, Universitas Al Azhar Indonesia, Jakarta 12110, Indonesia
People living with HIV (PLHIV) are considered a high-risk population for developing a severe form of COVID-19. Vaccination is still one of the most important modalities in combating the disease due to the lack of an effective treatment. This multicenter study was performed from September to December 2021 with the aim to analyze the intention of PLHIV to receive the COVID-19 vaccination based on an integrated behavior model (IBM) in Indonesia. Of a total of 470 participants, 75.6% of patients were intent to be vaccinated. The model that was designed in this study explains 43.4% of the variance in intention to be vaccinated against COVID-19 in PLHIV (adjusted R2 = 0.434). Furthermore, the determinants used included instrumental attitude (β = 0.127, p p p < 0.01). This study concluded that an IBM could predict the intention of PLHIV to receive COVID-19 vaccination.